Effect of thromboxane A(2) antagonists on bronchial hyperresponsiveness induced immediately after interleukin-8 inhalation in guinea-pigs

被引:5
作者
Fujimura, M
Myou, S
Nomura, M
Matsuda, T
Harada, A
Mukaida, N
Matsushima, K
Nonomura, A
机构
[1] KANAZAWA UNIV, SCH MED, DEPT HYG, KANAZAWA, ISHIKAWA 920, JAPAN
[2] KANAZAWA UNIV, SCH MED, DEPT PHARMACOL, CANC RES INST, KANAZAWA, ISHIKAWA 920, JAPAN
[3] KANAZAWA UNIV HOSP, PATHOL SECT, KANAZAWA, ISHIKAWA 920, JAPAN
关键词
interleukin-8; bronchial responsiveness; thromboxane A(2);
D O I
10.1038/sj.bjp.0701478
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Although repeated intranasal administration of interleukin-8 (IL-8) causes bronchial hyperresponsiveness (BHR) mediated via thromboxane A(2) (TXA(2)) and airway neutrophil accumulation in guineapigs, the acute effect of inhaled IL-8 is unclear. We performed this study to clarify the acute effect of IL-8 on bronchial responsiveness and the role of TXA(2). 2 The effects of inhaled IL-8 on bronchial responsiveness and of the TXA(2) antagonists, S-1452 (0.01 and 0.1 mg kg(-1)) and ONO-NT-126 (1.0 or 10 mu g kg(-1)), on IL-8-induced BHR were examined by use of a modified Konzett-Rossler method in guinea-pigs. 3 Inhaled IL-8 at 100 ng ml(-1), which failed to induce significant changes in Pao (pressure at the airway opening), enhanced an increase in Pao induced by subsequent inhalations of ascending doses (50-200 mu g ml(-1)) of methacholine and histamine, suggesting the potentiating effect of IL-8 on bronchial responsiveness. No significant leukocyte infiltration was observed histologically sixteen minutes after the IL-8 inhalation. Both S-1452 and ONO-NT-126 reduced the IL-8-induced BHR. 4 In conclusion, IL-8 rapidly causes BHR via TXA(2) release in guinea-pigs.
引用
收藏
页码:1015 / 1020
页数:6
相关论文
共 36 条
[1]  
BURROWS LJ, 1989, BR J PHARM S, V98, P789
[2]  
CHENG HC, 1982, ARZNEIMITTELFORSCH, V32-2, P1160
[3]  
COLLINS PD, 1993, IMMUNOLOGY, V79, P312
[4]   THE NEUTROPHIL-ACTIVATING PEPTIDE NAF/NAP-1 INDUCES HISTAMINE AND LEUKOTRIENE RELEASE BY INTERLEUKIN-3-PRIMED BASOPHILS [J].
DAHINDEN, CA ;
KURIMOTO, Y ;
DEWECK, AL ;
LINDLEY, I ;
DEWALD, B ;
BAGGIOLINI, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (05) :1787-1792
[5]   EFFECT OF A THROMBOXANE-A2 RECEPTOR ANTAGONIST (AA-2414) ON BRONCHIAL HYPERRESPONSIVENESS TO METHACHOLINE IN SUBJECTS WITH ASTHMA [J].
FUJIMURA, M ;
SAKAMOTO, S ;
SAITO, M ;
MIYAKE, Y ;
MATSUDA, T .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1991, 87 (01) :23-27
[6]   EFFECTS OF A THROMBOXANE SYNTHETASE INHIBITOR (OKY-046) AND A LIPOXYGENASE INHIBITOR (AA-861) ON BRONCHIAL RESPONSIVENESS TO ACETYLCHOLINE IN ASTHMATIC SUBJECTS [J].
FUJIMURA, M ;
SASAKI, F ;
NAKATSUMI, Y ;
TAKAHASHI, Y ;
HIFUMI, S ;
TAGA, K ;
MIFUNE, JI ;
TANAKA, T ;
MATSUDA, T .
THORAX, 1986, 41 (12) :955-959
[7]   Involvement of thromboxane A(2) in bronchial hyperresponsiveness of asthma [J].
Fujimura, M ;
Nakatsumi, Y ;
Nishi, K ;
Kasahara, K ;
Matsuda, T .
PULMONARY PHARMACOLOGY, 1995, 8 (06) :251-257
[8]  
FUJIMURA M, 1983, Japanese Journal of Allergology, V32, P365
[9]   CHARACTERIZATION OF A NEW COMPOUND, S-145, AS A SPECIFIC TXA2 RECEPTOR ANTAGONIST IN PLATELETS [J].
HANASAKI, K ;
ARITA, H .
THROMBOSIS RESEARCH, 1988, 50 (03) :365-376
[10]   EFFECT OF AN INHALED THROMBOXANE MIMETIC (U46619) ON AIRWAY FUNCTION IN HUMAN-SUBJECTS [J].
JONES, GL ;
SAROEA, HG ;
WATSON, RM ;
OBYRNE, PM .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (06) :1270-1274